About 100 reports

IVDs have already tremendously impacted cancer diagnosis and treatment globally by gaining deeper insights into genetic pathways of the disease enabled by human genome sequencing.

  • In Vitro Diagnostics
  • Point Of Care Testing
  • World
  • Market Size

It is possible to decipher the entire genetic content of an individual and has paved way for personalized medicine.

  • Point Of Care Testing
  • Abbott Laboratories, Inc.
  • Danaher Corporation
  • Roche Group
  • Thermo Fisher Scientific, Inc.
  • Point Of Care Testing
  • Forecast
  • Alere Inc.
  • Beckman Coulter, Inc.
  • BioFire Diagnostics, Inc.
  • MEXICO - IMMUNOASSAY MARKET VALUE BY SEGMENT, 2016 VS. 2021
  • MICROBIOLOGY/MOLECULAR

THIS GROUP WILL SUPPORT GENETIC DISEASE TESTING, ROUTINE TESTING AND MONITORING TESTING TECHNOLOGIES.

  • Point Of Care Testing
  • Mexico
  • Becton Property Group
  • Danaher Corporation
  • Roche Group

##. ##. ## Point of care Diagnostics – The Most Prominent Type of IVD ##. ##. ## Clinical Chemistry is Increasing in Complexity ##. ##. ## Microbiology ##. ##. ##. ## Regulatory Differences with IVD Microbiology Tests ##. ##. ## Haematology ##. ##. ## Immunochemistry ##. ##. ## Genetic Testing ##.

  • In Vitro Diagnostics
  • Point Of Care Testing
  • World
  • Market Size
  • SIEMENS HEALTHINEERS COMPANY SUMMARY
  • MICROBIOLOGY/MOLECULAR

Infectious disease testing is the driving force in the microbiology/ molecular IVD market with oncology indications and genetic disease testing following.

  • Point Of Care Testing
  • Brazil
  • Alere Inc.
  • Becton Property Group
  • bioMerieux S.A.
  • GLOBAL IVD QUALITY CONTROL MARKET SIZE FOR

SeraCare Life Sciences had partnership with AAB Proficiency Testing Service (AAB) for the development and use of preimplantation genetic screening (PGS) reference materials.

  • Point Of Care Testing
  • World
  • Market Size
  • Randox Laboratories Ltd.
  • SeraCare Life Sciences, Inc.
  • 1.4 IVD Market by Technology
  • 3.6 Global Microbiology Market

It is a technique to find how the individual' s genetic code and their cells express their genes as protein by applying molecular biology to medical testing.

  • Point Of Care Testing
  • World
  • Market Size
  • Abbott Laboratories, Inc.
  • Danaher Corporation

This acquisition helped the company to develop a differentiated NGS portfolio that provides customers with a complete genetic testing solution.

  • Point Of Care Testing
  • World
  • Market Size
  • QIAGEN N.V.
  • Roche Group

Marnes La Coquette Maxim Biomedical Inc Medford Medix Biochemica Medor Menarini Meridian Bioscience Mitsubishi Chemical MIZUHO MEDY Company Myriad Genetic Laboratories, Inc.

  • Diagnostics
  • In Vitro Diagnostics
  • Point Of Care Testing
  • World
  • Market Size

Becton, Dickinson And Company hormones, tumor markers, drugs of abuse, cardiac markers, infectious diseases, food safety, genetically modified organisms, and food safety.

  • Point Of Care Testing
  • Alere Inc.
  • Beckman Coulter, Inc.
  • bioMerieux S.A.
  • Chembio Diagnostics, Inc.
  • POINT OF CARE DIAGNOSTICS MARKET SEGMENTATION
  • 5 POINT OF CARE DIAGNOSTICS MARKET, BY TECHNOLOGY

DEVICES INTENDED TO BE USED IN THE DIAGNOSIS OF INFECTIOUS DISEASES, CANCER, AND HUMAN GENETIC TESTING IS INCLUDED UNDER CLASS C DEVICES.

  • Point Of Care Testing
  • World
  • Market Size
  • DexCom, Inc.
  • Medtronic, Inc.
  • Point Of Care Testing
  • France
  • Abbott Laboratories, Inc.
  • Alere Inc.
  • Beckman Coulter, Inc.

" WE ARE NOW EXPANDING THE MENU OF GENETIC TESTS OFFERED THROUGH BHL AND ARE DELIGHTED TO GAIN ACCESS TO JEAN' S BREADTH OF EXPERIENCE IN CLINICAL LABORATORY MANAGEMENT AND GENETIC TESTING. "

  • Point Of Care Testing
  • North America
  • Forecast
  • Market Size
  • Thermo Fisher Scientific, Inc.

The recent outbreak of H##N## influenza viruses led to the technological development of disposable microfluidic chip for genetic analysis of H##N## virus from throat swab specimens.

  • Point Of Care Testing
  • World
  • Forecast
  • Alere Inc.
  • Quidel Corporation

Its product portfolio includes advanced technologies for genetic sequencing and real-time, digital, and end-point PCR that can determine meaningful genetic information in applications such as human identification testing, cancer diagnostics, animal health, and inherited and infecti

  • Point Of Care Testing
  • Becton Property Group
  • Millipore Corporation
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

Crucial deals in 2012 include Hologic' s acquisition of Gen-Probe and Life Technologies' acquisition of Navigenics, a genetic testing laboratory.

  • Point Of Care Testing
  • Market Size
  • Danaher Corporation
  • Roche Group
  • Thermo Fisher Scientific, Inc.

Reagents related to human genetic testing. ##.

  • Point Of Care Testing
  • China
  • Abbott Laboratories, Inc.
  • Mindray Medical International Limited
  • Roche Group
  • Impact of drivers and challenges
  • Market challenges

PART ##: Impact of drivers Drivers Impact of drivers Impact on key customer category DIRECT-TO-CONSUMER (DTC) GENETIC TESTING PART ##: Market challenges DTC genetic testing is offered by private companies instead of healthcare providers.

  • Point Of Care Testing
  • Europe
  • Market Size
  • Alere Inc.
  • Roche Group

It also provides food analysis test kits for the analysis of mycotoxins, antibiotics, hormones, genetically modified organisms, risk material, food allergens and microorganisms.

  • Point Of Care Testing
  • Brazil
  • South America
  • Abbott Laboratories, Inc.
  • Alere Inc.

CLINICAL DIAGNOSTIC SEGMENT INCLUDES PRODUCTS FOR DIABETES MONITORING, BLOOD TYPING, BLOOD VIRUS TESTING, AUTOIMMUNE AND GENETIC DISORDER TESTING.

  • Diabetes Monitoring
  • Hospital
  • Medical Device
  • Patient Monitoring
  • Point Of Care Testing
  • THERMO FISHER SCIENTIFIC REVENUE (2012Ͳ2015) ($ MILLIONS)
  • ABBOTT DIAGNOSTICS

NEO NEW ONCOLOGY IS A SPECIALIST IN NGS TESTING FOR CANCER AND GENETIC DISEASES.

  • Point Of Care Testing
  • United States
  • Beckman Coulter, Inc.
  • Danaher Corporation
  • Roche Group

genetic mutations.

  • In Vitro Diagnostics
  • Point Of Care Testing
  • Alere Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.

Genetic Testing Growth Opportunity ##—Geographical Expansion to Eastern Europe ##.

  • In Vitro Diagnostics
  • Point Of Care Testing
  • Europe
  • Market Size

THERMO FISHER SCIENTIFIC IS ONE OF THE LEADING COMPANIES IN THE GENETIC TESTING AND PRECISION LABORATORY EQUIPMENT MARKETS.

  • Point Of Care Testing
  • World
  • Forecast
  • Roche Group
  • Thermo Fisher Scientific, Inc.
  • Market drivers

For instance, coagulation disorders are increasing due to the following conditions: GENETIC DISORDER SUCH AS HEMOPHILIA Prevalence Occurs more in males.

  • Point Of Care Testing
  • World
  • Abbott Laboratories, Inc.
  • Alere Inc.
  • F. Hoffmann-La Roche Ltd.
  • MARKET OUTLINE
  • DIAGNOSTIC LABORATORIES

IDENTIFICATION OF SUCH GENETIC MATERIAL CAN HELP TO DETECT GENETIC EXPRESSION, WHICH HELPS TO DETECT DISEASES.

  • Genome Sequencing
  • Point Of Care Testing
  • Market Size
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.

THE TBG FACILITY COMMENCED HLA TYPING IN XIAMEN IN JULY 2016 AND CONTINUES TO BUILD ON ITS CORE TECHNOLOGIES OF IVD - & SHYRELATED NUC LEIC ACID TESTING KITS, TO INCLUDE INFECTIOUS DISEASES, ONCOLOGY, BLOOD SCREENING AND GENETIC TESTING.

  • Point Of Care Testing
  • Asia
  • Forecast
  • Market Size
  • Beckman Coulter, Inc.

genetic markers for antimicrobial resistance.

  • Point Of Care Testing
  • Alere Inc.
  • bioMerieux S.A.
  • DiaSorin S.p.A.
  • Roche Group

They are used to detect pathogens such as HIV or hepatitis viruses, as well as genetic disorders.

  • Point Of Care Testing
  • China
  • Abbott Laboratories, Inc.
  • Mindray Medical International Limited
  • Roche Group